FR2360315A1 - Produit immunogene atoxique a base de toxine du tetanos, son procede de preparation et son application therapeutique - Google Patents

Produit immunogene atoxique a base de toxine du tetanos, son procede de preparation et son application therapeutique

Info

Publication number
FR2360315A1
FR2360315A1 FR7723600A FR7723600A FR2360315A1 FR 2360315 A1 FR2360315 A1 FR 2360315A1 FR 7723600 A FR7723600 A FR 7723600A FR 7723600 A FR7723600 A FR 7723600A FR 2360315 A1 FR2360315 A1 FR 2360315A1
Authority
FR
France
Prior art keywords
toxin
atoxic
product based
tetanos
tetanus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7723600A
Other languages
English (en)
Other versions
FR2360315B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of FR2360315A1 publication Critical patent/FR2360315A1/fr
Application granted granted Critical
Publication of FR2360315B1 publication Critical patent/FR2360315B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/08Clostridium, e.g. Clostridium tetani
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention est relative à un produit immunogène atoxique à base de toxique du tétanos caractérisé par les paramètres suivants : a. contante de sédimentation S degrés 2 0W 5,66 +- 0,34 ; b. réaction immunologique avec de l'antitoxine du tétanos : partiellement identique avec celle de la toxine du tétanos ; c. réaction immunologique avec le fragment C : non identique ; d. poids moléculaire, déterminé par une électrophorèse sur gel à l'aide de dodécyl sulfate sodique, 95 000 +- 5 000. e. clivable par réduction en une fraction ayant un poids moléculaire de 45 000 +- 2 500 et une fraction qui est identique du point de vue immunologique au dérivé connu à chaîne légère de la toxine du tétanos et ayant un poids moléculaire de 48 000 +- 2 500 (déterminé chaque fois par électrophorèse à l'aide de dodécyl sulfate sodique). Ce produit est utilisable pour préparer un vaccin antitétanique.
FR7723600A 1976-07-31 1977-08-01 Produit immunogene atoxique a base de toxine du tetanos, son procede de preparation et son application therapeutique Granted FR2360315A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2634584A DE2634584C3 (de) 1976-07-31 1976-07-31 Atoxisches, immunogenes Produkt aus Tetanus-Toxin

Publications (2)

Publication Number Publication Date
FR2360315A1 true FR2360315A1 (fr) 1978-03-03
FR2360315B1 FR2360315B1 (fr) 1980-04-11

Family

ID=5984461

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7723600A Granted FR2360315A1 (fr) 1976-07-31 1977-08-01 Produit immunogene atoxique a base de toxine du tetanos, son procede de preparation et son application therapeutique

Country Status (18)

Country Link
JP (1) JPS5326319A (fr)
AT (1) AT362498B (fr)
AU (1) AU516191B2 (fr)
BE (1) BE857373A (fr)
CA (1) CA1099635A (fr)
DE (1) DE2634584C3 (fr)
DK (1) DK342577A (fr)
EG (1) EG12732A (fr)
FI (1) FI58500C (fr)
FR (1) FR2360315A1 (fr)
GB (1) GB1570958A (fr)
IE (1) IE45539B1 (fr)
IL (1) IL52617A (fr)
IT (1) IT1085660B (fr)
LU (1) LU77874A1 (fr)
NL (1) NL7708279A (fr)
NO (1) NO772704L (fr)
SE (1) SE7708693L (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516442D0 (en) * 1985-06-28 1985-07-31 Wellcome Found Cloned antigen

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1977 *

Also Published As

Publication number Publication date
FI58500C (fi) 1981-02-10
FR2360315B1 (fr) 1980-04-11
IE45539B1 (en) 1982-09-22
DE2634584B2 (de) 1979-03-22
DK342577A (da) 1978-02-01
DE2634584C3 (de) 1979-11-08
GB1570958A (en) 1980-07-09
JPS5326319A (en) 1978-03-11
AU516191B2 (en) 1981-05-21
IL52617A0 (en) 1977-10-31
EG12732A (en) 1979-09-30
IE45539L (en) 1978-01-31
NL7708279A (nl) 1978-02-02
FI772305A (fr) 1978-02-01
SE7708693L (sv) 1978-02-01
DE2634584A1 (de) 1978-02-02
BE857373A (fr) 1978-02-01
IT1085660B (it) 1985-05-28
NO772704L (no) 1978-02-01
CA1099635A (fr) 1981-04-21
LU77874A1 (fr) 1978-02-02
FI58500B (fi) 1980-10-31
AU2738077A (en) 1979-02-01
IL52617A (en) 1980-12-31
ATA563477A (de) 1980-10-15
AT362498B (de) 1981-05-25

Similar Documents

Publication Publication Date Title
SE7505411L (sv) Antigraviditetsvaccin
Brenneman et al. The generation of antihapten antibodies with electrophoretically homogeneous L chains.
NL7509136A (nl) Werkwijze ter bereiding van preparaten tegen infectieziekten, alsmede als zodanig verkregen preparaten.
BG60017B2 (bg) Метод за намаляване хетерогенността на моноклонални антитела
BE876489A (fr) Preparation d'iso-alpha-acides par isomerisation d'alpha-acides extraits du houblon
IT1017868B (it) Procedimento per la preparazione in alta resa di copolimeri dello etilene con 1.3 butadiene
FR2298358A1 (fr) Adjuvant pour ameliorer la retention, l'egout
GB1411043A (en) Phenylglycines
FR2360315A1 (fr) Produit immunogene atoxique a base de toxine du tetanos, son procede de preparation et son application therapeutique
CA934295A (en) Vaccine for immunization of poultry against marek's disease
BE827125A (fr) Procede ameliore pour la preparation de l'hexanediol-1,6
FR2427823A1 (fr) Vaccin pour la prevention et le traitement de la trichophytie causee par trichophyton montagrophytes, et procede d'obtention dudit vaccin
FR2292486A1 (fr) Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de microbacteries et autres micro-organismes
SU719505A3 (ru) Способ получени 7 -/ -2амино-2-(низший алкилсульфониламинофенил)ацетиламино/-3-метокси-3-цефем-4карбоновых кислот и их солей
BE819319A (fr) Nouveaux derives d'acide carbonique de 2-mercapto-4,5-dichlorothioazole.
IT1148013B (it) Procedimento per ottenere preparati di tossoplasmi per la diagnosi del la tossoplasmosi e preparati cosi' ottenuti
DK46988A (da) Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf
FR2371462A1 (fr) Biogomme facilement dispersable
SU73939A1 (ru) Способ очистки и концентрации антитоксических лечебных сывороток
ES482549A0 (es) Un metodo para la preparacion de una composicion de virus herpes
SU462872A1 (ru) Способ охлаждени труб
RU95117092A (ru) Антитела, смесь антител, fab-фрагмент, линии гибридомных клеток, способы создания линий клеток, способ борьбы с вирусом, способ снижения уровня антигена, днк
Gold et al. Comparison of Polypeptide Chains of γG-Globulin from Bursectomized and Normal Chickens.
SU940848A1 (ru) Способ электродинамической сепарации
SU458368A1 (ru) Способ обжима концов трубных заготовок

Legal Events

Date Code Title Description
ST Notification of lapse